Letters to the Editor
Vol. 18 No. 1 (2026): Mediterranean Journal of Hematology and Infectious Diseases
Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurosyphilis.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: February 28, 2026
453
Views
191
Downloads
70
HTML
Authors
Background: Myelodysplastic syndrome (MDS) comprises a group of clonal myeloid neoplasms characterized by ineffective hematopoiesis, chronic cytopenias, and the potential for transformation to acute myeloid leukaemia . Environmental factors such as toxins, drugs, and infections can mimic dysplasia or exert selective pressure on mutated haematopoietic stem cells; however, persistent bone‑marrow failure after eradication of infection is uncommon.
Downloads
Download data is not yet available.
Citations
Garcia Manero G, et al. Myelodysplastic syndromes: 2023 update on diagnosis, risk stratification, and management. Am J Hematol 2023;98:1307–1325.
CDC – Sexually Transmitted Infections Treatment Guidelines (2021; updated 2024).
Hormaechea Agulla D, Matatall KA, Le DT, et al. Chronic infection drives DNMT3A loss of function clonal hematopoiesis via IFNγ signaling. Cell Stem Cell 2021;28:1428 1442.
Khadija Rafiq et al. The immunobiology of myelodysplastic neoplasms: a mini review. Frontiers in Immunology 2024;15:1419807.
National Cancer Institute (NCI). Myelodysplastic Syndromes Treatment (PDQ®️) – Health Professional Version. Updated 19 Sep 2024.
Centers for Disease Control and Prevention (CDC). Notes from the Field: Neurosyphilis, Ocular Syphilis, and Otosyphilis — Chicago, January–October 2023.
Medscape Reference. Myelodysplastic Syndrome (MDS) Treatment & Management (updated 14 Jun 2024).
How to Cite
“Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurosyphilis”. (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1), p. e2026026. doi:10.4084/MJHID.2026.026.
Copyright (c) 2026 Ali Turunç, Hüseyin Derya Dinçyürek, Birol Güvenç
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
